Which companies overlap with China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/china-resources-sanjiu-medical-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase
Jinfukang oral liquid	Jinfukang oral liquid	marketed
Yuxuebi tablet	Yuxuebi tablet	marketed
Shenfu Zhusheye	Shenfu Zhusheye	marketed

Therapeutic area mix

No therapeutic area data.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/china-resources-sanjiu-medical-pharmaceutical-co-ltd. Accessed 2026-05-17.